ArticleJournal of Indian Society of Periodontology
Multivariate analysis of treatment choices, disease activity, comorbidities, and oral impairments in rheumatoid arthritis patients.
Article in Journal of Indian Society of Periodontology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease that affects the synovial joints and is often associated with multiple comorbidities. Emerging evidence suggests a bidirectional link between RA and periodontal inflammation, wherein shared inflammatory mediators contribute to disease severity and therapeutic outcomes. Objective: The objective of the study was to examine the relationships among demographic and clinical characteristics, comorbidities, periodontal impairment assessed using Russell's Periodontal Index, systemic disease activity measured by Disease Activity Score (DAS28) and C-reactive protein (CRP), and treatment regimens in patients with RA. Materials and Methods: A cross-sectional cohort of 33 patients clinically diagnosed with RA (21 seropositive and 12 seronegative) was analyzed. Demographic, serological, and clinical data were retrieved from medical records and verified during follow-up consultations. Russell's Index was used to quantify periodontal involvement, whereas disease activity was assessed using the DAS28 score, which incorporates CRP levels. Details of comorbidities and prescribed treatments, hydroxychloroquine (HCQ), corticosteroids, or combination therapy, were documented. Descriptive and correlational analyses were performed to evaluate associations between disease activity, oral impairment, and therapeutic approach. Results: The cohort comprised 91% females, with a mean age of 46.5 ± 9.8 years. Seropositive RA was identified in 64% of patients. The mean Russell's Index was 2.42 in the RA Conclusion: Both systemic comorbidities and oral inflammatory burden influence RA severity. Integrating periodontal assessment with systemic disease monitoring enables more precise, personalized therapy selection. Russell's Index, in conjunction with DAS28 and CRP, may serve as a useful adjunctive marker for therapeutic stratification in RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.